Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Abstract 5923: Human dose-escalation study of CD8⁺T-cell infiltration in solid malignancies with⁶⁸Ga-NODAGA-SNA006 by PET imaging

Cancer Res (2025) 85 (8_Supplement_1): 5923.

https://doi.org/10.1158/1538-7445.AM2025-5923

Published: 21 April 2025

View articletitled, Abstract 5923: Human dose-escalation study of CD8+T-cell infiltration in solid malignancies with68Ga-NODAGA-SNA006 by PET imaging

Journal Articles

Abstract 4288: Discovery of a small molecule inhibitor of ADAR1 for cancer immunotherapy

Zijun Chen, Liqiang Shen, Qi Zhao, Jing Lu, Weiliang Li, Wen Jin, Xiang Ji, Mengchao Shi, Haowei Zhu, Lin Wang, Leduo Zhang, Xianqi Kong, Dawei Chen, Tianlun Zhou, Jiasheng Lu

Cancer Res (2025) 85 (8_Supplement_1): 4288.

https://doi.org/10.1158/1538-7445.AM2025-4288

Published: 21 April 2025

View articletitled, Abstract 4288: Discovery of a small molecule inhibitor of ADAR1 for cancer immunotherapy

Journal Articles

Abstract 263: Histone hypoacetylation of CD9 mediates differentiation arrest and immune evasion in pediatric acute myeloid leukemia

Yaqun Xu, Kathy Yuen Yee Chan, Qiwei Sun, Yixuan Wu, Siu Ping Fok, Qi Zhao, Gernot Schabbauer, Kam Tong Leung

Cancer Res (2025) 85 (8_Supplement_1): 263.

https://doi.org/10.1158/1538-7445.AM2025-263

Published: 21 April 2025

View articletitled, Abstract 263: Histone hypoacetylation of CD9 mediates differentiation arrest and immune evasion in pediatric acute myeloid leukemia

Journal Articles

Abstract 3410: Fc engineering of CD9 antibodies mitigates platelet toxicity and retains potency against acute lymphoblastic leukemia

Wing Hei Ng, Shengyu Fu, Kathy Yuen Yee Chan, Kin Yi Chung, Yuen Ching Tiffany Hui, Qi Zhao, Kam Tong Leung

Cancer Res (2025) 85 (8_Supplement_1): 3410.

https://doi.org/10.1158/1538-7445.AM2025-3410

Published: 21 April 2025

View articletitled, Abstract 3410: Fc engineering of CD9 antibodies mitigates platelet toxicity and retains potency against acute lymphoblastic leukemia

Journal Articles

Abstract 4786: A humanized monoclonal antibody targeting the Ig-like V1-C1 domains of B7-H3 suppresses the growth of breast cancer

Fengjuan Zhang, Qi Zhao

Cancer Res (2025) 85 (8_Supplement_1): 4786.

https://doi.org/10.1158/1538-7445.AM2025-4786

Published: 21 April 2025

View articletitled, Abstract 4786: A humanized monoclonal antibody targeting the Ig-like V1-C1 domains of B7-H3 suppresses the growth of breast cancer

Journal Articles

Abstract A028: The Early Detection Initiative trial version 2: A platform trial to test novel approaches to pancreatic cancer screening in patients with new onset hyperglycemia and diabetes

Ying-Qi Zhao, Suresh T. Chari, Anirban Maitra, Lynn M. Matrisian, Eva E. Shrader, Bechien U. Wu, Avinash Kambadakone, Barbara Kenner, Jo Ann S. Rinaudo, Sudhir Srivastava, Ying Huang, Ziding Feng

Cancer Res (2022) 82 (22_Supplement): A028.

https://doi.org/10.1158/1538-7445.PANCA22-A028

Published: 15 November 2022

View articletitled, Abstract A028: The Early Detection Initiative trial version 2: A platform trial to test novel approaches to pancreatic cancer screening in patients with new onset hyperglycemia and diabetes

Journal Articles

Abstract 2868: ADG206, an anti-CD137 agonistic POWERbody࣪ with tailor-made efficacy and safety profiles by strong crosslinking and tumor selective activation for single and combinational cancer immunotherapy

Guizhong Liu, Zhengxi Dai, Jiagui Qu, Jianfeng Shi, Qi Zhao, Linhai Qu, Yan Li, Songmao Zheng, Jiangchun Xu, Felix Du, Peter Luo

Cancer Res (2022) 82 (12_Supplement): 2868.

https://doi.org/10.1158/1538-7445.AM2022-2868

Published: 15 June 2022

View articletitled, Abstract 2868: ADG206, an anti-CD137 agonistic POWERbody࣪ with tailor-made efficacy and safety profiles by strong crosslinking and tumor selective activation for single and combinational cancer immunotherapy

Journal Articles

Abstract 5004: Integrative quality control of cancer somatic mutations with CaMutQC

Xin Wang, Jian Ren, Qi Zhao

Cancer Res (2022) 82 (12_Supplement): 5004.

https://doi.org/10.1158/1538-7445.AM2022-5004

Published: 15 June 2022

View articletitled, Abstract 5004: Integrative quality control of cancer somatic mutations with CaMutQC

Journal Articles

Abstract 2888: Tumor-targeted CD28 bispecific POWERbody࣪ for safe and synergistic T cell-mediated immunotherapy

Guizhong Liu, Zhengxi Dai, Jiagui Qu, Jianfeng Shi, Qi Zhao, Bin Cai, Aaron N. Nguyen, Songmao Zheng, Jiangchun Xu, Yan Li, Felix Du, Peter Luo

Cancer Res (2022) 82 (12_Supplement): 2888.

https://doi.org/10.1158/1538-7445.AM2022-2888

Published: 15 June 2022

View articletitled, Abstract 2888: Tumor-targeted CD28 bispecific POWERbody࣪ for safe and synergistic T cell-mediated immunotherapy

Journal Articles

Abstract 2869: ADG138, a novel HER2×CD3 POWERbody™ integrating bispecific TCE with precision masking to control cytokine release syndrome and on-target off-tumor toxicity for single agent and combination therapies in HER2-expressing solid tumors

Guizhong Liu, Yan Li, Zhengxi Dai, Jiagui Qu, Jianfeng Shi, Qi Zhao, Linhai Qu, Aaron N. Nguyen, Songmao Zheng, Jiangchun Xu, Felix Du, Peter Luo

Cancer Res (2022) 82 (12_Supplement): 2869.

https://doi.org/10.1158/1538-7445.AM2022-2869

Published: 15 June 2022

View articletitled, Abstract 2869: ADG138, a novel HER2×CD3 POWERbody™ integrating bispecific TCE with precision masking to control cytokine release syndrome and on-target off-tumor toxicity for single agent and combination therapies in HER2-expressing solid tumors

Journal Articles

Abstract 5754: The molecular characteristics of EGFR co-mutations in lung adenocarcinoma

Yanhong Shang, Hao Zhang, Aiming Zang, Shaohua Yuan, Xiaofang Li, Wenpan Zhang, Ran Huo, Guotao Fang, Zhengyue Dou, Weiwei Liu, Xiao Han, Qi Zhao, Chenglin Xi

Cancer Res (2022) 82 (12_Supplement): 5754.

https://doi.org/10.1158/1538-7445.AM2022-5754

Published: 15 June 2022

View articletitled, Abstract 5754: The molecular characteristics of EGFR co-mutations in lung adenocarcinoma

Journal Articles

MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1

Qi-Nian Wu, Xiao-Jing Luo, Jia Liu, Yun-Xin Lu, Yun Wang, Jingjing Qi, Ze-Xian Liu, Qi-Tao Huang, Ze-Kun Liu, Jia-Bin Lu, Ying Jin, Heng-Ying Pu, Pei-Shan Hu, Jia-Bo Zheng, Zhao-Lei Zeng, Huai-Qiang Ju, Dan Xie, Qi Zhao, Ruihua Xu

Cancer Res (2021) 81 (10): 2636–2650.

https://doi.org/10.1158/0008-5472.CAN-20-3747

Published: 15 May 2021

View articletitled, MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1

Includes: Supplementary data

Journal Articles

Correction: ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis

Yun-Xin Lu, Huai-Qiang Ju, Ze-Xian Liu, Dong-Liang Chen, Yun Wang, Qi Zhao, Qi-Nian Wu, Zhao-lei Zeng, Hai-Bo Qiu, Pei-Shan Hu, Zhi-Qiang Wang, Dong-Sheng Zhang, Feng Wang, Rui-Hua Xu

Cancer Res (2019) 79 (14): 3789.

https://doi.org/10.1158/0008-5472.CAN-19-1611

Published: 15 July 2019

View articletitled, Correction: ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis

Journal Articles

Abstract 4242: Systematic transcriptome analysis of small cell carcinoma of esophagus suggests a possibility for immunotherapy

Qi Zhao, Yan-xing Chen, Ying-nan Wang, Qi-nian Wu, Hui Sheng, JIa-jia Hu, Yun-xin Lu, Ze-xian Liu, Zhi-xiang Zuo, Feng Wang, Rui-hua Xu

Cancer Res (2019) 79 (13_Supplement): 4242.

https://doi.org/10.1158/1538-7445.AM2019-4242

Published: 01 July 2019

View articletitled, Abstract 4242: Systematic transcriptome analysis of small cell carcinoma of esophagus suggests a possibility for immunotherapy

Journal Articles

Abstract 4161: Germline mutational profileof Chinese patients with colorectal cancer and diagnosed lower than 70 years

Feng Wang, Qi Zhao, Teng-jia Jiang, Ying-nan Wang, Fu-rong Liu, Jia-jia Hu, Pei-rong Ding, Zhi-zhong Pan, Jian-yong Shao, Rui-hua Xu

Cancer Res (2019) 79 (13_Supplement): 4161.

https://doi.org/10.1158/1538-7445.AM2019-4161

Published: 01 July 2019

View articletitled, Abstract 4161: Germline mutational profileof Chinese patients with colorectal cancer and diagnosed lower than 70 years

Journal Articles

Abstract 5407: MicroRNA expression analysis of advanced colorectal cancer reveals a microRNA signature with prognostic and predictive value

Zhaolei Zeng, Jiahua Lu, Zhixiang Zuo, Qi Zhao, Ruihua Xu

Cancer Res (2018) 78 (13_Supplement): 5407.

https://doi.org/10.1158/1538-7445.AM2018-5407

Published: 01 July 2018

View articletitled, Abstract 5407: MicroRNA expression analysis of advanced colorectal cancer reveals a microRNA signature with prognostic and predictive value

Journal Articles

Abstract 2345: The genomic landscape of small cell carcinoma of the oesophagus

Feng Wang, Dongbing Liu, Qi Zhao, Gang Chen, Xinming Liu, Yingnan Wang, Hong Su, Yanru Qin, Yifu He, Qingfeng Zou, Yanhui Liu, Youen Lin, Hui Sheng, Jiajia Hu, Zexian Liu, Zhixiang Zuo, Jinxin Bei, Ruihua Xu

Cancer Res (2018) 78 (13_Supplement): 2345.

https://doi.org/10.1158/1538-7445.AM2018-2345

Published: 01 July 2018

View articletitled, Abstract 2345: The genomic landscape of small cell carcinoma of the oesophagus

Journal Articles

Abstract 4330: Pan-cancer analysis reveals m⁶A modification is functionally important in cancer

Zhixiang Zuo, Yubin Xie, Yueyuan Zheng, Peng Nie, Shuai Jiang, QI Zhao, Yanyan Miao, Jian Ren

Cancer Res (2018) 78 (13_Supplement): 4330.

https://doi.org/10.1158/1538-7445.AM2018-4330

Published: 01 July 2018

View articletitled, Abstract 4330: Pan-cancer analysis reveals m6A modification is functionally important in cancer

Journal Articles

Abstract 2263: The dysregulation of circadian genes across cancers

Zexian Liu, Huan Lin, Zekun Liu, Kai Yu, Qi Zhao, Xiaolong Zhang, Yan Wang, Zhixiang Zuo

Cancer Res (2018) 78 (13_Supplement): 2263.

https://doi.org/10.1158/1538-7445.AM2018-2263

Published: 01 July 2018

View articletitled, Abstract 2263: The dysregulation of circadian genes across cancers

Journal Articles

Abstract 3830: Monoclonal and bispecific antibodies against human insulin-like growth factors in oncology

Qi Zhao

Cancer Res (2018) 78 (13_Supplement): 3830.

https://doi.org/10.1158/1538-7445.AM2018-3830

Published: 01 July 2018

View articletitled, Abstract 3830: Monoclonal and bispecific antibodies against human insulin-like growth factors in oncology

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 5923: Human dose-escalation study of CD8⁺T-cell infiltration in solid malignancies with⁶⁸Ga-NODAGA-SNA006 by PET imaging

Abstract 4288: Discovery of a small molecule inhibitor of ADAR1 for cancer immunotherapy

Abstract 263: Histone hypoacetylation of CD9 mediates differentiation arrest and immune evasion in pediatric acute myeloid leukemia

Abstract 3410: Fc engineering of CD9 antibodies mitigates platelet toxicity and retains potency against acute lymphoblastic leukemia

Abstract 4786: A humanized monoclonal antibody targeting the Ig-like V1-C1 domains of B7-H3 suppresses the growth of breast cancer

Abstract A028: The Early Detection Initiative trial version 2: A platform trial to test novel approaches to pancreatic cancer screening in patients with new onset hyperglycemia and diabetes

Abstract 2868: ADG206, an anti-CD137 agonistic POWERbody࣪ with tailor-made efficacy and safety profiles by strong crosslinking and tumor selective activation for single and combinational cancer immunotherapy

Abstract 5004: Integrative quality control of cancer somatic mutations with CaMutQC

Abstract 2888: Tumor-targeted CD28 bispecific POWERbody࣪ for safe and synergistic T cell-mediated immunotherapy

Abstract 2869: ADG138, a novel HER2×CD3 POWERbody™ integrating bispecific TCE with precision masking to control cytokine release syndrome and on-target off-tumor toxicity for single agent and combination therapies in HER2-expressing solid tumors

Abstract 5754: The molecular characteristics of EGFR co-mutations in lung adenocarcinoma

MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1

Correction: ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis

Abstract 4242: Systematic transcriptome analysis of small cell carcinoma of esophagus suggests a possibility for immunotherapy

Abstract 4161: Germline mutational profileof Chinese patients with colorectal cancer and diagnosed lower than 70 years

Abstract 5407: MicroRNA expression analysis of advanced colorectal cancer reveals a microRNA signature with prognostic and predictive value

Abstract 2345: The genomic landscape of small cell carcinoma of the oesophagus

Abstract 4330: Pan-cancer analysis reveals m⁶A modification is functionally important in cancer

Abstract 2263: The dysregulation of circadian genes across cancers

Abstract 3830: Monoclonal and bispecific antibodies against human insulin-like growth factors in oncology

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only